Single Ascending Dose Study of PRX003 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Psoriasis

Interventions

DRUG

PRX003

OTHER

Placebo

Trial Locations (1)

Worldwide Clinical Trials Early Phase Services, San Antonio

All Listed Sponsors

lead

Prothena Biosciences Limited

INDUSTRY

NCT02458677 - Single Ascending Dose Study of PRX003 in Healthy Subjects | Biotech Hunter | Biotech Hunter